A secret sauce to the cure of the patients with the immunodeficiency disease X-SCID was bone marrow conditioning with the chemotherapy drug busulfan, according to a publication in the New England Journal of Medicine.
Telemedicine proponents have argued for years that virtual care is at least as effective as in-person care delivered in a traditional clinical setting. Based on new research, they may be more right than they had thought.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Early next year, UCSF will release a questionnaire meant to create a longitudinal picture of health issues related to LGBTQ communities.
CMS announced the second batch of prospective recipients of its Health Care Innovation Awards, which brings the total amount of funding for the project to about $360 million for health systems that devise new, innovative ways to curb healthcare costs among high-risk patients. Prospective winners are selected based on “compelling new ideas to deliver better […]
A team of doctors pressed for time used DNA testing to diagnose a rare bacterial infection in a 14-year-old boy with encephalitis. The case, written up in the New England Journal of Medicine and widely covered in media reports this week, represents what could one day become commonplace as medical innovations make it easier to […]
If you are a proud new life sciences startup owner, founder, employee or, hey, even that guy tinkering with an idea in his basement, you need to be reading Steve Blank‘s “Reinventing Life Science Startups” series on LinkedIn. Blank has been part of eight Silicon Valley startups, teaches entrepreneurship at several universities and is a board […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Another early stage California company in stealth mode has garnered a round of financing. This time it’s a biotech company called Nurix Inc., founded by three University of California, San Francisco and University of California, Berkeley researchers to leverage their drug discovery platform and develop new therapeutics for inflammatory diseases. Nurix revealed the closing of […]